pharmaceutical salts thereof, and/or solvates of any of the foregoing, which are useful for treating diseases and conditions related to mutant KIT and PDGFRα and present an advantageously non-brain penetrant profile for treating diseases and conditions related to mutant KIT and PDGFRα. The present disclosure also provides methods for treating gastrointestinal stromal tumors and systemic mastocytosis."/>
公开/公告号US10829493B2
专利类型
公开/公告日2020-11-10
原文格式PDF
申请/专利权人 BLUEPRINT MEDICINES CORPORATION;
申请/专利号US202016842969
发明设计人 THOMAS A. DINEEN;
申请日2020-04-08
分类号C07D487/04;A61P35;A61P43;
国家 US
入库时间 2022-08-21 11:28:15